By 5D on Thursday, 17 June 2021
Category: Blog

Major grant Awarded for Innovative Heart Treatment Devices with University of St Andrews

5D are delighted to be involved in developing this exciting technology alongside collaborators and partners at the University of St Andrews, University of the Highlands and Islands, Queen's University Belfast, MTC - Manufacturing Technology Centre, and Lubrizol Life Science - Health #medicaldevices#health #lifescience #healthcare #healthtech #scienceandtechnology#cardiology #nitricoxide #thrombosis

A collaboration to create a new generation of medical devices which could radically reduce the risks and complications of treating coronary heart disease, led by the University of St Andrews, has been awarded a major funding grant of nearly £1m.

The project, a collaboration with Queen's University Belfast, University of the Highlands and Islands, the Manufacturing Technology Centre and 5D Health Protection Group, will use the £967,008 grant from the Engineering and Physical Sciences Research Council (EPSRC) to create prototype devices designed to make the treatment of coronary heart disease (the common cause of heart attack and angina) easier and safer.

The team has developed novel materials that allow the release of an active agent called nitric oxide (NO) from the surface of medical devices. NO can prevent problems such as blood clotting and spasm which frequently occur when deploying medical devices inside arteries.

https://news.st-andrews.ac.uk/archive/major-grant-for-innovative-heart-treatment-devices/